Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



*Salve Harshala D., Handore Ankita R., Dr. L. B. Borse and Dr. Anil G. Jadhav


In an unprecedented effort to obtain scientific data during the SARS-CoV-2 pandemic, the World Health Organization (WHO) has announced the new SOLIDARITY trial that would include thousands of patients from around the world (45 countries and counting), and which has been designed to be as simple as possible in order to encourage all hospitals with confirmed cases to participate. Although scientists have suggested various existing compounds for testing as potential therapeutic agents, the WHO will focus on the four most promising therapies: Remdesivir, chloroquine and hydroxychloroqunine, lopinavir and ritonavir, Interferon-Beta in combination with, lopinavir and ritonavir.

Keywords: COVID-19; chloroquine; hydrochloroquine; lopinavir; ritonavir; remdesivir; SARS-CoV-2.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More